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SUMMARY 
TRIC channel subtypes, namely TRIC-A and TRIC-B, are intracellular monovalent cation 
channels postulated to mediate counter-ion movements facilitating physiological Ca2+ release 
from internal stores. Tric-a-knockout mice developed hypertension during the daytime due to 
enhanced myogenic tone in resistance arteries. There are two Ca2+ release mechanisms in 
vascular smooth muscle cells (VSMCs); incidental opening of ryanodine receptors (RyRs) 
generates local Ca2+ sparks to induce hyperpolarization, while agonist-induced activation of 
inositol trisphosphate receptors (IP3Rs) evokes global Ca2+ transients causing contraction. 
Tric-a gene ablation inhibited RyR-mediated hyperpolarization signaling to stimulate 
voltage-dependent Ca2+ influx, and adversely enhanced IP3R-mediated Ca2+ transients by 
overloading Ca2+ stores in VSMCs. Moreover, association analysis identified single nucleotide 
polymorphisms (SNPs) around the human TRIC-A gene that increase hypertension risk and 
restrict the efficiency of antihypertensive drugs. Therefore, TRIC-A channels contribute to 
maintaining blood pressure, while TRIC-A SNPs could provide biomarkers for constitutional 











Ca2+ release from the endo/sarcoplasmic reticulum (ER/SR) regulates important cellular functions. 
Ryanodine receptors (RyRs) expressed in excitable cells and inositol 1,4,5-trisphosphate receptors 
(IP3Rs) distributed in almost all types of cells comprise a family of Ca2+ release channels that are 
structurally and functionally distinct from other known ion channels (Fleischer, 2008; Patterson et 
al., 2004). To regulate separate cellular functions, RyRs and IP3Rs are activated by different 
mechanisms and often generate Ca2+ signals with distinct spatiotemporal characteristics. For 
example, in vascular smooth muscle cells (VSMCs), spontaneous RyR opening generates local Ca2+ 
sparks that activate cell-surface Ca2+-dependent K+ channels leading to hyperpolarization, while 
agonist-induced IP3R activation evokes global Ca2+ transients, which frequently accompany Ca2+ 
waves and oscillations, inducing contraction (Berridge, 2008; Wellman and Nelson, 2003). 
When Ca2+ is released from the ER/SR, a negative potential probably arises in the lumen that 
would disturb subsequent Ca2+ release. Therefore, physiological Ca2+ release likely requires 
counter-ion movements to balance ER/SR membrane potential (Meissner, 1983). We have identified 
TRIC (trimeric intracellular cation) channels that form bullet-shaped homo-trimers to function as 
monovalent cation channels (Pitt et al., 2010; Yazawa et al., 2007). Recent our studies in mutant 
embryonic cardiomyocytes, alveolar epithelial cells and skeletal myocytes from knockout mice 
indicate that TRIC channels act as counter-ion channels facilitating physiological ER/SR Ca2+ 
release (Yamazaki et al., 2009; Zhao et al., 2010). However, the vital roles of TRIC channel 
subtypes, designated TRIC-A and TRIC-B, still remain to be investigated in various tissues. We 
report here the essential contribution of TRIC-A channels to SR Ca2+ handling in VSMCs for blood 




RESULTS AND DISCUSSION 
Hemodynamic Abnormalities in Tric-a-Knockout Mice 
Tric-a-knockout mice are normal in terms of growth, reproduction and motor function (Yazawa et 
al., 2007). However, skeletal muscle preparations from the knockout mice occasionally generate 
alternan contractions likely due to incidental SR Ca2+ overloading, and also exhibit membranous 
vacuolation in SR segments (Zhao et al., 2010). On the other hand, telemetric monitoring of 
hemodynamics (Figure 1A and B) detected high BP and slow heart rate (HR) in the knockout mice 
even at young-adult stages (8−12 weeks old). Both hypertensive and bradycardiac phenotypes were 
detected during daytime when sympathetic stimuli are inactivated. The hemodynamic profiles 
suggested that the knockout mice maintain circadian BP and HR oscillations, and both the 
phenotypes were eliminated in nighttime when sympathetic outputs are facilitated. Therefore, 
autonomic controls are probably important in developing the phenotypes. Furthermore, tail-cuff 
measurements carried out during daytime confirmed these phenotypes in the knockout mice (Figure 
1C). 
 
Hypertensive Phenotype in Tric-a-Knockout Mice 
To survey the mechanism of daytime hypertension in Tric-a-knockout mice, we examined 
pharmacological effects, induced by the submaximal doses of various vasodepressors and evaluated 
as BP shifts in tail-cuff measurements (Figures 1D and S1). Because resistance vessels are not 
directly regulated by vagal outputs, as expected, the muscarinic antagonist atropine did not affect 
the hypertensive phenotype. In response to the -antagonist prazosin, which inhibits sympathetic 
vasoconstriction, Tric-a-knockout and control mice showed similar BP reduction. Therefore, when 
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sympathetic controls are abolished in resistance arteries, Tric-a-knockout mice seem to retain the 
hypertensive phenotype. This assumption was supported by vasodilating responses to the 
-agonist clonidine, which pre-synaptically attenuates sympathetic adrenaline/noradrenaline 
release. Moreover, inhibitors for various vasoactive factors induced essentially the same effects in 
both genotypes, suggesting that excessive secretion of endogenous vasopressors is not associated 
with Tric-a-knockout hypertension. It is worthy of note that the Ca2+ channel antagonists 
nicardipine and verapamil exerted potent depressor actions in the knockout mice and canceled the 
hypertensive phenotype. 
Comparable to the manner in which C19ORF42 lies with TRIC-A on the human chromosome 
(Figure 6A), its ortholog 9130011J15Rik is adjacent to Tric-a in the mouse genome (Figure S2A). 
In Tric-a-knockout mice, the ectopic neomycin-resistance gene is inserted into the 5’-terminal 
region of the Tric-a gene to disrupt the first exon (Yazawa et al., 2007) and could also affect 
9130011J15Rik gene expression, leading to the hypertensive phenotype. However, the involvement 
of this putative gene was eliminated by our observations. Quantitative RT-PCR analysis detected 
that 9130011J15Rik expression was similar in various tissues from the knockout and control mice 
(Figure S2B and C). Moreover, transgenic mice expressing TRIC-A channels under the control of 
the -smooth muscle actin promoter were generated and bred with Tric-a-knockout mice (Figure 
S2D−H). The Tric-a transgene was abundantly expressed in tissues containing SMCs and rescued 
hypertension developed under Tric-a-knockout conditions. The hypertension-rescue mice, together 
with remarkable vasodilation induced by Ca2+ channel antagonists in Tric-a-knockout mice, suggest 
that abnormalities in SMCs expressing L-type Ca2+ channels are primarily responsible for the 
pathogenesis of the hypertensive phenotype. 
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Bradycardiac Phenotype in Tric-a-Knockout Mice 
When atropine and the 1-antagonist metoprolol were co-administered to inhibit autonomic 
controls to the heart, tail-cuff measurements detected similar intrinsic HRs between Tric-a-knockout 
and control mice (Figure 1C), suggesting normal pacemaking in the mutant hearts. In single-agent 
administration, atropine remarkably elevated HR to cancel the bradycardiac phenotype, while the 
heart-slowing metoprolol maintained the phenotype in the knockout mice. Therefore, vagal 
hyperactivity during daytime is the direct cause of the bradycardiac phenotype. Predominant 
sympathetic stimuli probably prevent this phenotype during nighttime. 
The Rho kinase inhibitor Y27632, -antagonist prazosin, angiotensin II AT1-receptor blocker 
candesartan and Ca2+ channel antagonists primarily act in vessels. These vessel-targeted depressors 
obviously attenuated the bradycardiac phenotype in Tric-a-knockout mice (Figure S1), indicating 
that vagal hyperactivity is induced by baroreceptor reflexes activated under hypertensive conditions. 
Therefore, baroreflex-mediated vagal hyperactivity, together with sympathetic inactivation during 
daytime, probably promotes the bradycardiac phenotype in the knockout mice. However, the 
phenotype was not canceled in the hypertension-rescue mice bearing the SMC-specific Tric-a 
transgene (Figure S2H). Although the rescue mice possess a highly artificial genetic feature, this 
observation may suggest that neuronal defects, together with activated baroreflexes, take part in 
vagal hyperactivity. Atypical autonomic activity in the knockout mice is presumed from another 
side and discussed elsewhere (see the section “Mechanism of Tric-a-Knockout Hypertension”). 
 
Elevated MyogenicTone in Tric-a-Knockout Artery 
Because the in vivo experiments suggested that hypertension is a primary defect in Tric-a-knockout 
mice, we next focused on the mutant vessels. Elevation of intravascular pressure causes constriction 
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of VSMCs in resistance arteries, and this behavior, known as myogenic tone, is a key element for 
BP maintenance (Segal, 1994). The mesenteric artery, a typical resistance vessel, was cannulated 
with micropipettes to measure its diameter under a video-monitored perfusion system. Despite 
showing normal passive diameters in a Ca2+-free bathing solution (Figure S3A−C), Tric-a-knockout 
arteries had narrower diameters at the intraluminal pressure levels examined when compared with 
control arteries (Figure 2A). Therefore, spontaneous myogenic tone was significantly elevated in 
the mutant arteries (Figure 2B), and this abnormality seems to directly develop hypertension in 
Tric-a-knockout mice. Spontaneous myogenic tone may be broadly elevated throughout the 
vascular system of the knockout mice, because isometric tension measurements detected elevated 
resting tone in aortic ring preparations from Tric-a-knockout mice (Figure S4C−F). On the other 
hand, normal morphology and gene expression were observed in the mutant vessels (Figure S3D 
and E), suggesting no vascular remodeling in Tric-a-knockout mice. Moreover, in the 
hypertension-rescue mice, the SMC-specific Tric-a transgene restored elevated myogenic tone 
developed under Tric-a-knockout conditions to normal levels (Figure 2C). 
In response to acetylcholine, the vasorelaxation factors, nitric oxide (NO) and unidentified 
endothelium-derived hyperpolarizing factor (EDHF), are produced in endothelial cells, and their 
vasodilating effects can be evaluated using inhibitors attenuating either signaling pathway (Busse et 
al., 2002; Koshita et al., 2007). Although acetylcholine-induced relaxation was obviously facilitated 
likely due to elevated spontaneous myogenic tone in Tric-a-knockout arteries, fractional rates of 
NO- and EDHF-dependent relaxation were similar between the mutant and control arteries (Figure 
S4A and B). Therefore, it is rather unlikely that insufficient vasorelaxation signaling in endothelial 
cells underlies Tric-a-knockout hypertension. 
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Abnormal Ca2+-Handling in Tric-a-Knockout VSMCs 
Vascular tonus is controlled by the contraction of VSMCs primarily regulated by intracellular Ca2+ 
signaling (Segal, 1994). NO and EDHF syntheses also depend upon Ca2+ signaling in endothelial 
cells (Busse et al., 2002). RT-PCR detected co-expression of Tric-a and Tric-b mRNAs in VSMCs 
and endothelial cells (Figure S5A and B), providing the possibility that TRIC-A channel deficiency 
may affect both cell types. In Fura-PE3 ratiometric Ca2+ imaging of mesenteric arteries lacking 
endothelial cells, we detected irregular Ca2+ handling in Tric-a-knockout VSMCs, which were 
categorized into three abnormalities as described below. In contrast, Tric-a-knockout endothelial 
cells in primary culture retained normal Ca2+-handling properties (Figure S5C−I). 
The first abnormality of Tric-a-knockout VSMCs was the elevation of resting intracellular Ca2+ 
concentration ([Ca2+]i). Elevated resting [Ca2+]i was attenuated by Ca2+-free bathing solutions and 
verapamil (Figure 2D), while inhibitors of Orai and TRP channels (Smyth et al., 2006) were 
ineffective (Figure S4I−L). The L-type Ca2+ channel agonist BayK8644 remarkably increased 
resting [Ca2+]i in control VSMCs, but not in the mutant VSMCs (Figure 2E). Therefore, enhanced 
steady-state Ca2+ influx through L-type Ca2+ channels probably elevates resting [Ca2+]i in the 
mutant VSMCs. This assumption was confirmed by the observations that verapamil-sensitive Mn2+ 
influx was significantly facilitated and Mn2+ influx was insufficiently activated by BayK8644 in the 
mutant VSMCs (Figure S6A−C). The proposed hyperactivation of L-type Ca2+ channels was not 
caused by increased channel density or altered channel gating (Figure S6D and E). Moreover, 
elevated resting [Ca2+]i and enhanced L-type Ca2+ channel currents were also indicated in aortic 
SMCs from the knockout mice (Figure S4G and H). In the hypertension-rescue mice, the 
SMC-specific transgene reset elevated resting [Ca2+]i induced under Tric-a-knockout conditions 
(Figure 2E). 
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The second abnormality was SR Ca2+-overloading, as Ca2+ leak responses evoked by the ER/SR 
Ca2+-pump inhibitor cyclopiazonic acid were obviously enhanced in Tric-a-knockout VSMCs 
(Figure 2F and G). SMCs contain distinct Ca2+ stores equipped with either RyRs or IP3Rs, called 
caffeine- and IP3-sensitive stores respectively, that partially overlap and functionally interact 
(Berridge, 2008). Caffeine-sensitive stores were not overloaded in Tric-a-knockout VSMCs, 
because the RyR activator caffeine induced similar transients in the mutant and control cells (Figure 
2H and I). The third abnormality was in facilitated agonist-induced Ca2+ release; the 1-agonist 
phenylephrine evoked enhanced IP3R-mediated Ca2+ transients in Tric-a-knockout VSMCs (Figure 
2J and K). In the mutant VSMCs, normal Ca2+ release was induced by caffeine immediately after 
enhanced phenylephrine-evoked transients under Ca2+-free conditions (Figure 2L and M). Therefore, 
the Tric-a deficiency probably induces Ca2+ overloading specifically in IP3-sensitive stores. Because 
submicromolar [Ca2+]i potentiates IP3R activation (Iino, 1990), the enhanced driving force of the 
overloaded luminal Ca2+, together with elevated resting [Ca2+]i, likely facilitate IP3R-mediated 
responses in the mutant VSMCs. 
 
Impaired Hyperpolarization Signaling in Tric-a-Knockout VSMCs 
In SMCs, incidental RyR activation generates Ca2+ sparks (Cheng and Lederer, 2008; Nelson et al., 
1995) and evokes spontaneous transient outward currents (STOCs) (Ohi et al., 2001; Wray and 
Burdyga, 2010). High-speed fluorometric imaging detected Ca2+ sparks with regular amplitudes 
generated at hot spots in single Tric-a-knockout VSMCs (Figure 3A−D). However, the frequency of 
Ca2+ sparks was noticeably reduced in the mutant cells perfused with a high-K+ solution. On the 
other hand, among the three major types of Ca2+-dependent K+ channels classified using specific 
inhibitors (Wei et al., 2005), iberiotoxin-sensitive big-conductance (BK) channels predominantly 
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mediated STOCs in VSMCs from mesenteric arteries (Figure S6F). In patch-clamp recording, 
Tric-a-knockout VSMCs exhibited reduced STOC frequency at high membrane potentials (Figure 
3E and F), but they nonetheless retained normal STOC amplitudes (Figure 3G), cell-surface BK 
channel density and gating feature (Figure S6G and H). Since the reduced STOC frequency is fully 
consistent with the insufficient spark generation, hyperpolarization signaling generated by 
functional coupling between RyRs and BK channels is probably compromised in Tric-a-knockout 
VSMCs. Meanwhile, weak Ca2+ sparks and STOCs just above the detection limits are always 
observed in the measurements, but cannot be generally evaluated in the statistical analyses. 
Although our measurements showed no differences between the genotypes in a normal bathing 
solution, such miniature events might be insufficiently evoked under resting conditions and 
steady-state excitability could be altered in Tric-a-knockout VSMCs. 
 
Enhanced Excitability in Tric-a-Knockout VSMCs 
In confocal-microscopic imaging in the continuous presence of the voltage-dependent dye oxonol 
VI, depolarization results in accumulation of the dye into cells to subsequently increase cellular 
fluorescence intensity (Apell and Bersch, 1987). The intensity monitored was normalized to the 
maximum value in a 140 mM KCl bathing solution to yield a fractional intensity (F/F140K) as an 
index of membrane potential (Figure 4A). In a normal bathing solution, an increased fractional 
intensity was detected in Tric-a-knockout VSMCs, demonstrating the elevation of resting 
membrane potential (Figure 4B). To analyze the relationship between the fractional intensity and 
membrane potential, intensity shifts were monitored in several high K+-bathing solutions and the 
membrane potentials were estimated by the Nernst equation. Direct microelectrode measurements 
have determined a resting membrane potential of -59.9 ± 3.0 mV in VSMCs from mouse mesenteric 
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arteries (Koshita et al., 2007). The prepared calibration plot estimated a resting membrane potential 
of -54.6 ± 1.7 mV in Tric-a-knockout VSMCs (Figure 4C). BK channel blockage with iberiotoxin 
markedly elevated resting potential in control VSMCs, but not in Tric-a-knockout cells (Figure 4D). 
Additionally, a BK channel opener notably induced vasodilation in the mutant mesenteric arteries, 
but not in control arteries (Figure S4A). Therefore, BK channel-mediated STOCs take part in 
maintaining resting membrane potential in VSMCs and spontaneous tonus in resistance arteries, but 
this mechanism is probably impaired in Tric-a-knockout arteries. This conclusion is confirmed by 
the hypertension-rescue mice; the poor sensitivity to iberiotoxin and elevated resting potential were 
restored by the SMC-specific Tric-a transgene (Figure 4B and D). 
We also examined the repolarizing phase of VSMCs after 60 mM KCl-induced depolarization. 
Tric-a-knockout VSMCs showed prolonged repolarizing phases in a normal bathing solution, while 
the mutant and control VSMCs exhibited similar repolarization in the presence of iberiotoxin 
(Figure 4E and F). Therefore, BK channels contribute to accelerating repolarization as well as 
maintaining resting potential in VSMCs. In Tric-a-knockout VSMCs, insufficient STOCs likely 
prolong both depolarizing durations and L-type Ca2+ channel opening events. 
 
Mechanism of Tric-a-Knockout Hypertension 
In SMCs, persistent Ca2+ influx through L-type channels seems to maintain resting [Ca2+]i and may 
refill intracellular stores for further release processes without direct activation of SR Ca2+ release 
(Amberg et al., 2007; Berridge, 2008). Based on the poor Ca2+ spark generation in Tric-a-knockout 
VSMCs (Figure 3), we propose that TRIC-A channels primarily facilitate RyR-mediated Ca2+ 
release by providing counter-ion movements across the SR membrane in VSMCs (Figure 5). 
Because the compromised Ca2+ sparks evoke insufficient STOCs (Figure 3), resting membrane 
 12 
potential is elevated and depolarization is prolonged in Tric-a-knockout VSMCs (Figure 4). Under 
such ‘sensitized’ conditions, L-type Ca2+ channels are hyperactivated causing elevated resting 
[Ca2+]i in the mutant VSMCs and enhancing myogenic tone in the mutant vessels (Figures 2, S4 and 
S6). The proposed pathogenic mechanism is consistent with the observations that Tric-a-deficient 
hypertension is highly sensitive to Ca2+ channel antagonists (Figure 1), and that the SMC-specific 
Tric-a transgene in the hypertension-rescue mice restored key defects developed under 
Tric-a-knockout conditions (Figures 2 and 4). In addition to the poor Ca2+ spark generation, 
TRIC-A channel deficiency produced Ca2+-overload in the SR and adversely potentiated 
IP3R-mediated Ca2+ release in VSMCs (Figure 2). Therefore, facilitated agonist-induced Ca2+ 
transients in response to sympathetic stimuli also could elevate vascular tonus. However, this 
mechanism may not obviously contribute to Tric-a-knockout hypertension, because prazosin 
induced similar vasodilatation in the knockout and control mice (Figure 1). 
   Tric-a-knockout mice developed both hypertension and bradycardia under the control of the 
autonomic nervous system (Figure 1). While impaired hyperpolarization signaling in VSMCs 
continuously elevates spontaneous vascular tonus, hypertension was masked during nighttime in the 
knockout mice. Therefore, it may be that sympathetic activity of Tric-a-knockout mice is adjusted 
lower during nighttime compared to that of control mice. However, this presumption may conflict 
with our HR monitoring observations. As discussed above, daytime bradycardia seems to be mainly 
due to baroreflex-mediated vagal hyperactivity. During nighttime, normal sympathetic and vagal 
activities are reasonably proposed in the knockout mice, based on their regular HRs under 
normotensive conditions. The discrepancy between sympathetic activities proposed on the basis of 
BP and HR monitoring cannot be explained by the baroreflex depression, in which baroreflex 
sensitivity becomes attenuated as hypertension progresses. Although the pharmacological responses 
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and circadian hemodynamic profiles suggest that the central autonomic system is regularly 
functioning in the knockout mice, Tric-a gene ablation could induce mild autonomic imbalance to 
generate aberrant stimuli of targeted tissues. For example, TRIC-A channel deficiency might impair 
cellular functions in certain pre- or post-ganglionic neurons of the peripheral autonomic system, 
since TRIC channel subtypes are co-expressed in neurons (Yazawa et al., 2007). In addition to 
elevated vascular tonus as an absolute predisposing risk for hypertension, aspects of autonomic 
imbalance might contribute to the atypical hemodynamic features observed in Tric-a-knockout 
mice. 
 
Preferential Coupling between RyR and TRIC-A Channels in VSMCs 
In cardiomyocytes, RyRs are abundantly expressed in the SR, while IP3Rs presumably reside in 
perinuclear regions at low expression levels. Resulting caffeine- and IP3-sensitive stores seem to 
contribute to distinct Ca2+ signals regulating contraction and gene expression, respectively 
(Kockskämper et al., 2008). Knockout mice lacking both TRIC channel subtypes exhibit embryonic 
heart failure, and the mutant cardiomyocytes show compromised RyR-mediated Ca2+ release 
(Yazawa et al., 2007). Meanwhile, Tric-a-knockout and Tric-b-knockout mice undergo normal 
embryonic development, indicating that TRIC channel subtypes possess compatible functions in 
embryonic cardiomyocytes. However, in other cell types, subtype-specific coupling may be flexibly 
formed between Ca2+ release and TRIC channels. In alveolar type II epithelial cells, agonist-induced 
Ca2+ release stimulates the synthesis and secretion of surfactant phospholipids for lung expansion. 
Tric-b-knockout mice exhibit neonatal lethality due to respiratory failure, and the mutant alveolar 
type II cells show impaired IP3R-mediated Ca2+ release and insufficiently deal with surfactants 
(Yamazaki et al., 2009). In this case, functional coupling between IP3Rs and TRIC-B channels is set 
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by the gene expression profile; alveolar epithelial cells contain IP3Rs and TRIC-B channels, but 
expressions of RyRs and TRIC-A channels are undetectable. In skeletal muscle, RyRs and TRIC-A 
channels are abundantly distributed in the SR, while IP3Rs and TRIC-B channels are expressed at 
low levels. In Tric-a-knockout skeletal muscle, Ca2+ overloading and membranous vacuolation are 
developed in the SR likely due to compromised RyR-mediated Ca2+ release (Zhao et al., 2010). 
Although the abnormalities suggest selective coupling between RyRs and TRIC-A channels, it may 
be superficially formed according to predominant expression of TRIC-A channels. In contrast, 
VSMCs equip caffeine- and IP3-sensitive stores roughly equivalent in Ca2+ content (Figure 2) and 
contain Tric-a and Tric-b mRNAs at similar levels (Figure S5). Insufficient Ca2+ sparks and 
facilitated IP3R-mediated Ca2+ release in Tric-a-knockout VSMCs (Figures 2 and 3) clearly suggest 
preferential coupling between RyRs and TRIC-A channels, and reversely may further presume 
another coupling between IP3Rs and TRIC-B channels. However, the mechanism underlying the 
proposed subtype-selective coupling is unknown, and direct interaction between RyRs and TRIC 
channels was not detected in crosslinking experiments using skeletal muscle SR preparations 
(unpublished observation). The proposed coupling could be caused by restricted residency of TRIC 
channel subtypes in caffeine- or IP3-sensitive stores, and/or distinct channel characteristics 
electrophysiologically detected between the subtypes (Pitt et al., 2010). 
Even though TRIC-A channel deficiency inhibits RyR-mediated Ca2+ release, Tric-a-knockout 
VSMCs developed Ca2+-overloaded IP3-sensitive stores (Figure 2). This unexpected abnormality 
may predict the existence of ‘Ca2+ laundering’ between caffeine- and IP3-sensitive stores. For 
example, Ca2+ pumped into caffeine-sensitive stores bearing impaired Ca2+ release machinery might 
be transferred into IP3-sensitive stores retaining intact Ca2+ release assembly until it becomes 
overloaded in the mutant VSMCs. In addition to TRIC and Ca2+ release channels, many 
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Ca2+-handling proteins are cooperatively functioning in the ER/SR at quite different levels among 
cell types. Recent live cell imaging revealed that the ER/SR membranes exhibiting cell-type 
specific ultrastructures are dynamic networks, constantly remodeling in a condition-dependent 
manner. Such protein-compositional, morphological and kinetic characteristics could underlie the 
Ca2+ laundering, as well as the preferential channel coupling discussed above. To evaluate these 
mysterious mechanisms proposed by Tric-a-knockout mice, VSMCs lacking or overexpressing 
TRIC-B channels would provide useful model systems in our future studies. 
 
TRIC-A Variants Associated with Essential Hypertension 
It is important to define lifestyle habits and genetic variations associated with hypertension, because 
it is a major risk factor for stroke and ischemic heart disease. Although genome-wide studies have 
recently identified several single nucleotide polymorphisms (SNPs) associated with susceptibility to 
essential hypertension in the human genome (for example, Newton-Cheh et al., 2009), the 
relationship between hypertension and the TRIC-A (TMEM38A) gene is unknown. To survey 
genetic mutations causative for hypertension in the TRIC-A gene, we sequenced genomic segments 
from Japanese patients with severe hypertension. Although no mutation was found in the analysis, 
we observed several common TRIC-A SNPs in linkage disequilibrium (LD) (Figure S7A). The 
HapMap database for genetic variants tentatively classified SNPs around the TRIC-A gene into 
three blocks; block 1 lying >30 kb upstream of the TRIC-A gene, block 2 located in the putative 
promoter overlapping with the neighboring gene and block 3 covering the TRIC-A transcriptional 
region (Figures 6A and S7B). 
To examine the relationship between TRIC-A variants and hypertension, we conducted an 
association analysis of the tag SNPs selected from the LD blocks. In a Japanese population-based 
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case-control study using 1,119 hypertensive and 1,140 normotensive subjects (Table S1), PCR 
genotyping demonstrated that several LD SNPs in blocks 2 and 3 are positively associated with 
essential hypertension (Table 1). For example, in SNP rs901792 variations in block 3, the minor C 
allele with a frequency of ~30% was found to be a risk allele. The most significant association with 
hypertension was found at rs17796739, an LD SNP in block 2. All positively-associated SNPs in 
our analysis showed nearly absolute LD, i.e. LD=1 and high r2, and blocks 2 and 3 formed a single 
LD block spanning the entire TRIC-A gene in the Japanese population. On the other hand, no 
significant association was found in non-LD SNPs in block 2 or 3, or in SNPs in block 1 (Figure 6 
and Table 1). 
 
TRIC-A Variants Associated with Efficacy of Antihypertensive Drugs 
The “GEANE (Gene evaluation for antihypertensive effects of drugs) study” used ~130 Japanese 
hypertensive patients to examine the depressor effects of the angiotensin II AT1-receptor blocker 
valsartan (ARB), Ca2+ channel blocker amlodipine (CCB) and thiazide diuretic indapamide (TZD) 
at their standard doses (Table S2). When BP shifts were directly examined, microarray genotyping 
detected that these antihypertensive drugs are less effective for the hypertension risk allele 
homozygotes at LD SNP sites in the TRIC-A gene (Figure 6B and Table S3). For example, the 
patients with the CC genotype at rs901792 were low responders to the antihypertensive medications. 
When ARB-induced depressor effects were closely evaluated by adjusting for baseline BP values 
(Purcell et al., 2007), the CC-homozygous patients showed an insufficient diastolic BP (DBP) 
reduction compared to other genotypes, while no difference was detected in systolic BP (SBP) 
reduction between the genotypes (Figure 6C and Table S4). Therefore, the minor allele was 
associated with a DBP-resistant characteristic during ARB therapy. This significant association was 
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detected in four LD SNPs of blocks 2 and 3, but disappeared in SNPs of block 1. 
Weak association of the hypertension-risk SNPs with insufficient DBP reduction was also 
observed in TZD and CCB therapies (Figure 6C). However, it is worth noting that the relationships 
of DBP-lowering effects with SNP genotypes were slightly different among the antihypertensive 
medications. For example, risk allele homozygotes at rs8112375 and rs10403969 were 
significantly associated with ARB resistance. Similar trends were observed in the CCB therapy, 
while no association was indicated in the TZD therapy. However, it is clear that additional studies in 
more patients are required to directly link the hypertension-risk SNPs to their different 
pharmacological efficacies between the antihypertensive medications. 
 
TRIC-A Variants and Tric-a-Knockout Hypertension 
The presented data demonstrated that the TRIC-A LD-SNPs are associated with essential 
hypertension and reduce the efficacy of antihypertensive agents. Therefore, these SNPs can 
contribute to developing preventive care approaches and personalized medication to treat 
hypertension. However, the biological alterations induced by the TRIC-A variants remain to be 
investigated in future studies. Based on our data from Tric-a-knockout mice, it may be reasonably 
assumed that the TRIC-A minor allele as a hypertension risk is accompanied by weak gene 
expression in VSMCs. Indeed, the block 2 SNPs at the putative promoter region showed slightly 
lower p values in association with hypertension than the block 3 SNPs (Table 1). In this regard, 
there may be a discrepancy between observations from Tric-a-knockout mice and hypertensive 
patients, i.e. Tric-a-knockout mice were hypersensitive to Ca2+ channel antagonists (Figure 1), but 
amlodipine exerted poor depressor effects in hypertensive patients homozygous for the TRIC-A risk 
allele (Figure 6). However, the Ca2+ channel antagonists were administered at submaximal doses to 
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the knockout mice, while amlodipine was dispensed at a regular dose within the safety margin to 
the hypertensive patients. The knockout mice bearing apparently uniform genetic backgrounds 
develop monogenic hypertension, while combined multigenic factors and lifestyle habits including 
aging effects give rise to essential hypertension in human subjects with non-uniform genetic 
backgrounds. Therefore, appropriate care must be taken when directly comparing of the data from 
the knockout mice and hypertensive patients. 
Our finding with Tric-a-knockout mice redefined aspects of the contribution of SR 
Ca2+-handling in VSMCs to physiological BP maintenance. As in the case of TRIC-A channels, BK 
channels contribute to hyperpolarization signaling in VSMCs, and several variants of the BK 
channel subunit genes are highly associated with hypertension (Köhler, 2010). As well as the 
TRIC-A gene, our present observations may implicate the genes encoding other SR Ca2+-handling 




Hemodynamic and Myogenic Tone Measurements 
Tric-a-knockout mice were generated as described previously (Yazawa et al., 2007), and all 
experiments were predominantly designed using young-adult male mice (8−12 weeks old) in this 
study. For SMC-specific expression of TRIC-A channels, a transgene was constructed by inserting 
the mouse Tric-a cDNA between the -smooth muscle actin promoter and the polyadenylation 
sequence (Nakano et al., 1991). Circadian hemodynamic profiles were analyzed using implantable 
devices in telemetric BP and electrocardiogram monitoring systems (Data Sciences International, 
USA.). BP and HR were also monitored by conventional tail-cuff plethysmography (Softron, Japan). 
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Myogenic tone and isometric tension measurements in vascular preparations were carried out as 
described previously (Iwamoto et al., 2004). 
 
Physiological Measurements in VSMCs 
The vessel preparations were used for anatomical and gene expression analyses (Yazawa et al, 
2007; Hotta et al., 2007). To examine Ca2+ handling in VSMCs, endothelial cells were removed 
from vascular preparations, and the resulting segments were incubated with Fura-PE3AM and 
subjected to ratiometric imaging with excitation at 340 and 380 nm, and emission at >510 nm 
(Iwamoto et al., 2004). Cultured endothelial cells from the aorta were subjected to 
immunocytochemistry and Fura-2 Ca2+ imaging (Kobayashi et al., 2005). 
To monitor Ca2+ sparks, single VSMCs prepared from mesenteric arteries (Ohi et al., 2001) 
were incubated with Fluo-4AM, and subjected to imaging with excitation at 488 nm and emission at 
>520 nm using a total internal reflection fluorescence microscopy system. To monitor Mn2+ quench 
of Fura-2 fluorescence, VSMCs loaded with Fura-2AM were subjected to imaging with excitation 
at 360 nm and emission at >510 nm (Hashii et al., 2000). To measure K+ and Ca2+ channel currents, 
the whole-cell voltage clamp technique was applied to isolated VSMCs (Hotta et al., 2007; Ohi et 
al., 2001). Although widely used voltage-sensitive dyes often activate BK channels, such side 
effects of oxonol VI seem to be minimal (Morimoto et al., 2007). To monitor membrane potential 
using oxonol VI (Apell and Bersch, 1987), isolated VSMCs were subjected to confocal-microscopic 
imaging with excitation at 559 nm and emission at >606 nm (Masumiya et al., 2009). 
 
Case-Control and GEANE Studies 
Hypertensive cases and normotensive controls were recruited from several regions in Japan. 
 20 
Genomic DNAs from blood samples were genotyped with the TaqMan probe assay using primers 
and probes purchased from the Assay-on-Demand system (Applied Biosystems). Frequency 
differences in each SNP were assessed by the chi-square test. The GEANE study utilized an open 
random crossover protocol to examine the antihypertensive effects of ARB, TZD and CCB in 
untreated Japanese with essential hypertension. Before and after each drug medication for three 
months, BP was determined and blood samples were collected for SNP genotyping (Human 
Mapping 500K, Affymetrix). The data were examined in the two evaluation models (Purcell et al., 
2007): (i) linear regression for differences in BP from pre-medication to post-medication with only 
SNPs as a fixed effect (Figure 6B) and (ii) linear regression for post-medication BP with SNPs and 
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Table 1. Association of TRIC-A Tag SNPs with Essential Hypertension 
  
genotype frequency (n) association analysis Linkage disequilibrium 
hypertensive normotensive odds (95% CI) p block D' LOD r
2 
rs2363857 GG/GA/AA 1/40/1089 1/46/1065 
0.86 
(0.57−1.30) 0.47 block 1 0.826 3.72 0.004 
rs1020723 GG/GA/AA 3/73/1052 0/79/1032 
0.98 
(0.72−1.35) 0.92 block 1 0.586 2.00 0.004 
rs17796739 TT/TC/CC 75/390/624 54/378/683 
1.18 
(1.03−1.36) 0.018* block 2 reference 
rs2279448 CC/CT/TT 3/116/972 5/112/1006 
1.03 
(0.80−1.33) 0.816 block 2 1.000 13.98 0.018 
rs8101030 AA/AC/CC 92/437/576 75/416/634 
1.16 
(1.02−1.33) 0.026* block 2 0.995 617.54 0.843 
rs4808521 GG/GA/AA 97/455/555 87/428/614 
1.14 
(1.00−1.30) 0.048* block 3 0.913 436.24 0.666 
rs730120 AA/AG/GG 69/397/641 55/380/699 
1.16 
(1.01−1.33) 0.041* block 3 0.973 658.63 0.911 
rs901792 CC/CT/TT 114/481/496 108/444/558 
1.14 
(1.00−1.29) 0.048* block 3 0.928 384.36 0.587 
rs2431808 GG/GA/AA 9/170/952 11/167/928 
1.03 
(0.84−1.27) 0.779 block 3 0.185 0.52 0.001 
rs2279449 AA/AG/GG 26/247/829 31/276/824 
0.89 
(0.76−1.06) 0.189 block 3 0.984 35.20 0.048 
The case and control subjects were genotyped, and the data were analyzed using an allelic model. Statistical differences 
between the genotypes are indicated by an asterisk (*p<0.05). CI, confidence interval. The tag SNPs examined were 
selected from the 110-kb region (chromosome 19, 16560K to 16670K in the HapMap database), in which three LD 
blocks were proposed in the analysis using Haploview software (see Figure S7). Pairwise LD properties were calculated 
using rs17796739 as a reference; the standardized disequilibrium coefficient (D’), logarithm of odds (LOD) and squared 
















Figure 1. Hypertensive and Bradycardiac Phenotypes in Tric-a-Knockout Mice 
(A and B) Daytime hypertension and bradycardia in Tric-a-knockout mice. Circadian fluctuations in 
systolic BP (A) and HR (B) were telemetrically monitored, and the data were averaged over each 
2-hr interval during a 24 hr period. (C) BP and HR monitoring by tail-cuff plethysmography during 
daytime. Autonomic controls were blocked by intraperitoneal injections of the muscarinic 
antagonist atropine (Atr, 4 mg/kg) and -antagonist metoprolol (Met, 4 mg/kg). (D) BP-lowering 
effects of depressors at submaximal doses. Drugs injected intraperitoneally were Pra (1-antagonist 
prazosin, 1 mg/kg), Clo (2-agonist clonidine, 0.1 mg/kg), Can (angiotensin II AT1-receptor 
blocker candesartan, 10 mg/kg), BQ123 (endothelin A-receptor blocker, 1 mg/kg), OPC 
(vasopressin V1-receptror blocker OPC-21268, 10 mg/kg), Y27632 (Rho kinase inhibitor, 5 mg/kg), 
Nic (dihydropyridine Ca2+ antagonist nicardipine, 1 mg/kg), Ver (phenylalkylamine Ca2+ antagonist 
verapamil, 12 mg/kg), HOE (bradykinin antagonist HOE140, 1 mg/kg), and hAM (adrenomedullin 
antagonist hAM22‒52, 20 mg/kg). The data represent the mean ± SEM., and the numbers of mice 
examined are shown in parentheses. Statistical differences between the genotypes are indicated by 
asterisks (*p<0.05, **p<0.01 in t-test). 
 
Figure 2. Enhanced Tonus in Tric-a-Knockout Arteries and Abnormal Ca2+-Handling in 
Tric-a-Knockout VSMCs (A‒C) Myogenic tone measurements in mesenteric arteries. 
Representative recording data are shown in A. The dotted line indicates the passive diameter (PD) 
determined in a Ca2+-free solution. Myogenic tone (MT) is expressed as the difference between the 
steady-state and passive diameters at an intravascular pressure of 70 mmHg. The data for the 
pressure-diameter relationship and MT are summarized in B and C, respectively. (D‒M) Ca2+ 
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imaging in arterial VSMC segments. Representative effects of extracellular Ca2+ and L-type Ca2+ 
channel modulators on resting [Ca2+]i are shown in D, and the data are summarized in E. L-type 
Ca2+ channels were activated or inhibited by BayK8644 or verapamil, respectively. Representative 
SR Ca2+ leakage and store-operated Ca2+ entry responses (SOCE) are shown in F, and the data are 
summarized in G. Ca2+ leakage induced by the Ca2+-pump inhibitor cyclopiazonic acid (CPA) 
reflects total SR Ca2+ content. Representative Ca2+ transients induced by caffeine (Caf) are shown in 
H, and the data are summarized in I. Because caffeine activates RyRs, the Ca2+ transient represents 
the Ca2+ content of stores bearing RyRs. Representative agonist-induced Ca2+ transients are shown 
in J, and the data are summarized in K. Because the 1-agonist phenylephrine (PE) induces 
IP3R-mediated Ca2+ release, the Ca2+ transient reflects the Ca2+ content of stores bearing IP3Rs. 
Sequential responses upon PE and Caf under Ca2+-free conditions are shown in L, and the data are 
summarized in M. The data represent the mean ± SEM., and the numbers of mice examined are 
shown in parentheses. Statistical differences between the genotypes are indicated by asterisks 
(*p<0.05, **p<0.01 in ANOVA or t-test). Statistically significant drug-induced effects within each 
genotype are indicated by sharps (#p<0.05, ##p<0.01 in t-test). 
 
Figure 3. Impaired Hyperpolarization Signaling in Tric-a-Knockout VSMCs 
(A‒D) Ca2+ spark imaging. Single VSMCs were prepared from mesenteric arteries and loaded with 
Fluo-4 for total internal reflection fluorescence imaging. Ca2+ sparks were monitored in normal (5.9 
mM KCl) and high-K+ (60 mM KCl) bathing solutions. Representative data from the high-K+ 
measurements are shown in A. Ca2+ sparks generated at the numbered time points are shown as 
pseudocolor-coded images in upper panels. The intracellular fluorescence intensity was normalized 
to the baseline intensity to yield the relative intensity (F/F0), and time courses of the intensity 
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changes at the subcellular regions (see colored circles in the upper left images, scale bar = 10 m) 
are illustrated in the lower traces. The data on spark frequency (B), spark amplitude (C) and spark 
spot number (D) are summarized. (E‒G) STOC measurements. The membrane potential of isolated 
VSMCs was controlled by the whole-cell patch-clamp technique to monitor membrane currents. 
Representative recording data are shown in E. The data of STOC frequency (F) and amplitude (G) 
are summarized. The data represent the mean ± SEM., and the numbers of cells examined from at 
least 3 mice are shown in parentheses. Statistical differences between the genotypes are indicated by 
asterisks (*p<0.05, **p<0.01 in t-test).  
 
Figure 4. Enhanced Excitability in Tric-a-Knockout VSMCs 
In single VSMCs perfused with the bathing solution containing oxonol VI, cellular fluorescence 
intensities were monitored by confocal-microscopic imaging and normalized to the maximum value 
in the 140 mM KCl solution to yield the fractional intensity (F/F140K). Representative recoding data 
are shown in A. The data of the resting intensity are summarized in B. To prepare a calibration plot, 
the data from bathing solutions containing 5.9 (normal solution), 20, 30, 60 and 140 mM KCl, 
together with the reported value of resting membrane potential, are summarized in C; red and blue 
lines indicate the resting fractional intensity and estimated resting membrane potential of VSMCs 
prepared from the knockout and rescue mice, respectively. The data of the intensity shift by 
iberiotoxin (IBTX) are summarized in D. The decay time courses of the fluorescence intensity after 
replacing the 60 mM KCl bathing solution with the normal solution are shown in E; fluorescence 
intensities were normalized to the value in the 60 mM KCl solution. The half-decay time was 
significantly prolonged in Tric-a-knockout VSMCs under normal conditions, but no difference 
between the genotypes was observed in the presence of IBTX (F). The data represent the mean ± 
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SEM., and the numbers of cells examined from at least 3 mice are shown in parentheses. Statistical 
differences between the genotypes are indicated by asterisks (*p<0.05, **p<0.01 in t-test). 
 
Figure 5. Compromised Ca2+ signaling in Tric-a-Knockout VSMCs 
The loss of TRIC-A channels seems directly to inhibit Ca2+ spark generation mediated by RyRs, 
thus attenuating the hyperpolarization signaling produced by functional coupling between RyRs and 
BK channels and elevating resting membrane potential in VSMCs. In the situation, L-type Ca2+ 
channels (Cav) are hyperactivated and resting [Ca2+]i are elevated to develop enhanced spontaneous 
tonus in resistance arteries and hypertension in the knockout mice. Upon sympathetic stimulation, 
the 1-adrenoceptor (1AR), trimeric GTP-binding protein Gq, and phospholipase C (PLC) are 
coordinately activated to trigger IP3R-mediated Ca2+ release. In Tric-a-knockout VSMCs, poor Ca2+ 
sparks may conversely develop SR Ca2+ overloading to boost IP3R-mediated Ca2+ release as the 
contraction signaling. 
 
Figure 6. TRIC-A SNPs Associated with Hypertension and Antihypertensive Efficacy 
(A) LD plot of genomic region encompassing TRIC-A gene. The plot was illustrated with common 
SNPs and downloaded from the HapMap database. The C19ORF42 gene encodes a hypothetical 
protein. The transcriptional direction of each gene is indicated by an arrow. LD SNPs around the 
TRIC-A gene cluster to generate the blocks 1‒3 (block 1 is located outside of this map, see Figure 
S7B). Of SNPs genotyped in the case-control study (red rs ID), five SNPs showing significant 
association with hypertension (see Table 1) were in tight LD. Of eight SNPs examined in the 
GEANE study, five sites are localized in blocks 2 and 3 (blue rs ID), but three sites are in the 
3’-flanking region outside of the map region. Two SNPs were examined in both the case-control 
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and GEANE studies (purple rs ID). (B and C) In the GEANE study, valsartan (ARB), indapamide 
(TZD) and amlodipine (CCB) were administered at standard doses to hypertensive patients, and 
association of SNP genotypes with the hypotensive effects was examined. (B) When drug-induced 
reductions in mean BP (MBP) were compared among SNP genotypes, insufficient BP-lowering 
effects were found to be associated with minor allele homozygosity at TRIC-A LD-SNPs including 
rs901792. The data represent the mean ± SD., and the subject numbers are shown in parentheses. 
*p<0.05, **p<0.01 in t-test. (C) To further analyze the BP-lowering effects, SBP and DBP data 
were subjected to a regression analysis adjusting for baseline values before drug administration. In 
the bar graphs, the  values represent specific drug-induced effects in the minor allele homozygotes. 
The filled circles indicate p values (red circles, p<0.05 in t-test) at each SNP site. See Tables S3 and 
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Figure S1. Effects of Hypotensive Agents on BP and HR in Tric-a-Knockout Mice 
Pharmacological effects of various agents on systolic BP and HR were monitored by tail-cuff plethysmography in 
Tric-a-knockout and wild-type mice during daylight hours. Drugs used for the analysis are the muscarinic 
antagonist atropine (Atr, 4 mg/kg), 1-antagonist metoprolol (Met, 4 mg/kg), 1-antagonist prazosin (Pra, 1 mg/kg), 
2-agonist clonidine (Clo, 0.1 mg/kg), angiotensin II AT1-receptor blocker candesartan (Can, 10 mg/kg), 
endothelin A-receptor blocker BQ123 (1 mg/kg), vasopressin V1-receptor blocker OPC-21268 (OPC, 10 mg/kg), 
Rho kinase inhibitor Y27632 (5 mg/kg), dihydropyridine Ca2+ antagonist nicardipine (Nic, 1 mg/kg), 
phenylalkylamine Ca2+ antagonist verapamil (Ver, 12 mg/kg), bradykinin antagonist HOE140 (HOE, 1 mg/kg) and 
adrenomedullin antagonist hAM22−52 (hAM, 20 mg/kg). The data represent the mean ± SEM., and the numbers of 
mice examined are shown in parentheses. Statistical differences between the genotypes are indicated by asterisks 
(*p<0.05, **p<0.01 in t-test).

Figure S2. No Contribution of 9130011J15Rik Gene to Tric-a-Knockout Hypertension 
(A) Mouse genetic maps of wild-type and Tric-a-knockout alleles. The Tric-a gene (red) and the hypothetical gene 
(blue) are located close on chromosome 8B3.3. This proximity is probably shared by other mammalian genomes 
(see Figure 6 for the human genome). The putative genes encode hypothetical proteins, 9130011J15Rik in mouse 
and C19ORF42 in human, both of which are composed of 75 highly conserved amino acid residues. E1−E6 
indicate exons in the genes; filled and open boxes represent protein-coding and noncoding regions, respectively. In 
the mutant allele, the neomycin resistance gene (neo) is ectopically inserted into the exon 1 of the Tric-a gene. (B) 
Quantitative detection of 9130011J15Rik and Tric-b mRNAs in mouse tissues. Total tissue RNA preparations from 
at least 3 mice in each genotype were examined by quantitative RT-PCR. Amplified cDNAs were subjected to 
agarose gel electrophoresis, and representative data for cDNA amplification are presented. PCR cycle numbers are 
shown in parentheses, and 2-microglobulin (B2m) mRNA was examined as an internal control. (C) Relative 
contents of 9130011J15Rik and Tric-b mRNAs in mouse tissues. MA, mesenteric artery; EDL, extensor digitorum 
longus muscle. The quantitative RT-PCR experiments detected no significant difference in 9130011J15Rik or Tric-b 
mRNA expression between Tric-a-knockout and wild-type tissues. The cycle threshold (Ct) indicates the cycle 
number at which the amount of amplified cDNA reaches a fixed threshold in each RT-PCR reaction. (D) Maps of 
the endogenous Tric-a gene (EG) and the SMC-specific Tric-a transgene (TG). Synthetic primers for PCR analysis 
are indicated by arrows (for mouse genotyping) and arrowheads (for RT-PCR analysis). A hybridization probe used 
for Southern blot analysis of EcoRI-digested genomic DNAs is indicated by an open box. Transcriptional regions 
are marked by red boxes. (E) PCR genotyping for detection of the transgene in primary founder mice. Tail genomic 
DNAs from the mice were subjected to PCR using Tg-1 and Tg-2 primers, and amplified DNA fragments were 
analyzed by agarose gel electrophoresis. DNA fragments derived from the EG and TG are indicated by arrowheads. 
(F) Southern blot analysis of the transgene in founder mice. Tail genomic DNA (10 g in each lane) was digested 
with EcoRI for blot hybridization using the Tric-a cDNA probe. Hybridization-positive DNA fragments derived 
from EG and TG are indicated by arrowheads. (G) RT-PCR detection of Tric-a mRNAs derived from EG and TG. 
Total tissue RNA preparations from at least 3 mice in each genotype were examined by quantitative RT-PCR 
analysis. Amplified cDNAs were subjected to agarose gel electrophoresis and the representative data are presented. 
PCR cycle numbers and primer sets used are shown in parentheses (see panel D). (H) Tail-cuff monitoring of 
systolic BP and HR in Tric-a-knockout mice carrying the transgenic mice. The SMC-specific Tric-a transgene 
seemed to mediate strong hypotensive effects but insufficient HR-elevating effects in Tric-a-knockout mice. The 
data represent the mean ± SEM., and the numbers of mice examined are shown in parentheses. Statistical 
differences from the values of Tric-a-knockout mice are indicated by asterisks (**p<0.01 vs. A-/- mice in t-test). 
Primer sets used for DNA amplification are listed in Table S5. 
 
Figure S3. No Signs for Remodeling in Tric-a-Knockout Vessels 
(A‒E) Analyses of Tric-a-knockout mesenteric arteries. (A) Histology of Tric-a-knockout arteries. The third branch 
of the artery was immersed in Ca2+-free PSS supplemented with 4 mM EGTA, and then fixed and embedded in 
epoxy resin. Thin sections (approximately 1 µm thick) were stained with toluidine blue for light microscopic 
observation. (B) Summarized histological features in Tric-a-knockout arteries. The media diameter, lumen diameter, 
media thickness, media to lumen diameter and lumen cross sectional area (LCSA) of the arterial sections (n>18 
from 3 mice) were statistically analyzed using Image J software. (C) Passive diameters of arteries at various 
intravascular pressure levels. The diameter was measured in Ca2+-free Krebs-Ringer solution supplemented with 4 
mM EGTA, and the data were summarized. There were no statistical differences within any genotypes. (D) 
Electron-microscopic images of endothelial cells (EC), smooth muscle cells (SMC) and the cell membrane of 
SMCs (caveola) from mesenteric arteries. Our observations detected no abnormal ultrastructural features in 
Tric-a-knockout mesenteric arteries. (E) Quantitative RT-PCR analysis in Tric-a-knockout arteries. (F and G) 
Analyses of Tric-a-knockout thoracic aorta. (F) Photo- and electron-microscopic images of endothelial cells (EC), 
smooth muscle cells (SMC) and the cell membrane of SMCs (caveola) in Tric-a-knockout aortas. Our observations 
detected no abnormal ultrastructural features in the mutant aorta. (G) Quantitative RT-PCR analysis in 
Tric-a-knockout aortas. For the data presentation, mRNAs examined are categorized into five groups in E and G. 
Primer sets used for cDNA amplification are listed in Table S5. The data represent the mean ± SEM., and the 
numbers of mice examined are shown in parentheses. Although statistical evaluation detected a few significant 
differences between genotypes (see p values in t-test), the changes of mRNA contents seem minimal in 
Tric-a-knockout vessels. Therefore, the overall expression profiles are roughly unchanged between the genotypes. 
Taken together, we detected no signs of vascular remodeling in Tric-a-knockout mice at the young-adult stage. 
 
Figure S4. Characterization of Arterial Dilation, Aortic Contraction and Ca2+ Handling of VSMC in 
Tric-a-Knockout Mice 
(A and B) Dilation of mesenteric arteries. Arterial dilation was induced by the BK channel opener 12,14- 
dichlorodehydroabietic acid (1 M DiCl-DHAA, refer Sakamoto et al. (2006) J. Pharmacol. Exp. Ther. 316, 
144−153) or acetylcholine (0.1 M ACh), as measured by diameter monitoring at an intravascular pressure of 70 
mmHg. The BK channel opener induced potent vasodilation in Tric-a-knockout arteries, suggesting poor activity of 
BK channels under resting conditions in the mutant VSMCs. ACh-induced vasodilation was also enhanced in 
Tric-a-knockout arteries likely due to elevated myogenic tone under resting conditions in the mutant vessels. To 
evaluate NO-dependent vasodilation, ACh-induced relaxation was partially inhibited by the NO synthase inhibitor 
N-nitro-L-arginine methyl ester (100 M L-NAME). To estimate endothelium-derived hyperpolarizing factor 
(EDHF)-dependent vasodilation, the relaxation was partially inhibited by the intermediate-conductance 
Ca2+-dependent K+ (IK) channel blocker TRAM-34 (10 M) and the small-conductance Ca2+-dependent K+ (SK) 
channel blocker apamin (200 nM). Putative NO- and EDHF-dependent fractional vasodilations were calculated 
using the original ACh response as a reference. The lack of obvious differences in the fractional values between the 
genotypes suggests that NO- and EDHF-dependent vasodilations function normally in Tric-a-knockout arteries. 
(C−F) Contraction of thoracic aorta. (C and D) Aortic ring preparations were mounted on a fixed isometric force 
transducer, and resting tension was initially adjusted to 1 g. Contraction was evoked by the -agonist 
phenylephrine (1 M PE) or 60 mM KCl bathing solution, and relaxation was induced by a Ca2+-free bathing 
solution. (E and F) PE and 60 mM KCl-induced contraction and relaxation induced by Ca2+ removal were 
statistically analyzed. Tric-a-knockout specimens tended to generate weakened contraction and showed facilitated 
relaxation in the isometric tension measurements. These observations suggest that the resting myogenic tone is 
elevated in the mutant aorta. (G and H) Resting [Ca2+]i of aortic VSMCs. Endothelial cells were removed from 
aortic preparations and the resulting smooth muscle segments were loaded with Fura-PE3AM for ratiometric Ca2+ 
imaging. Effects of extracellular Ca2+ and L-type Ca2+ channel modulators on resting [Ca2+]i were examined, and 
the data obtained are summarized. Resting [Ca2+]i in Tric-a-knockout VSMCs was significantly elevated in the 
presence of extracellular 2 mM CaCl2, but became normal in Ca2+-free and verapamil-containing solutions. In 
response to BayK8644, resting [Ca2+]i was remarkably elevated in control VSMCs, but not in Tric-a-knockout 
VSMCs. These abnormal characteristics are shared by arterial and aortic VSMCs (see Figure 2). (I-J) 
Pharmacological characterization of Ca2+ handling in VSMCs. To examine the effects of Ca2+-handling inhibitors, 
Fura-PE3 Ca2+ imaging was carried out in mesenteric artery preparations lacking endothelial cells. Although SOCE 
evoked in VSMCs was sensitive to authentic SOCE inhibitors, 4-methyl-4′-[3,5-bis(trifluoromethyl)-1H-pyrazol-1- 
yl]-1,2,3-thiadiazole-5-carboxanilide (BTP2, 10 M), Gd3+ (10 M) and La3+ (10 M) (I), the inhibitors did not 
attenuate elevated resting [Ca2+]i in Tric-a-knockout VSMCs (J). Moreover, inhibitors of Na+-Ca2+ exchangers 
(YM-244769, 10 M), IP3 receptors (xestospongin C, 3 M) and phospholipase C (U73122, 10 M) exerted no 
significant effects on resting [Ca2+]i in the mutant VSMCs (K). These data are summarized in L. The observations 
suggest no essential contribution of SOCE, Ca2+ extrusion or IP3 signaling to the development of elevated resting 
[Ca2+]i in Tric-a-knockout VSMCs. The data represent the mean ± SEM., and the numbers of mice and experiments 
from at least 3 mice are shown in parentheses. Statistical differences between the genotypes are indicated by 
asterisks (*p<0.05, **p<0.01 in t-test). Statistically significant drug-induced effects within each genotype are 
indicated by sharps (#p<0.05, ##p<0.01 in t-test). 

Figure S5. Expression of TRIC Channel Subtypes in Mesenteric Artery, and Normal Ca2+ Handling in 
Tric-a-Knockout Endothelial Cells 
(A and B) Quantitative RT-PCR analysis of Tric-a, Tric-b, Ryr2, Cav1.2, Kcnn4 and Pecam1 mRNAs. Total RNA 
preparations were extracted from mesenteric arteries (MA) with or without endothelial cells (EC+/-), and primary 
cultured endothelial cells derived from the aorta (EC). Amplified cDNAs were subjected to agarose gel 
electrophoresis, and the representative data are presented. RCR cycle numbers are shown in parentheses, and 
2-microglobulin mRNA (B2m) was examined as an internal control. Primer sets used are listed in Table S5. The 
cycle threshold (Ct) was determined in each RT-PCR reaction, and the data were statistically examined. (C) 
Immunohistochemical analysis of primary cultured endothelial cells. Immunostaining with antibodies to platelet 
endothelial cell adhesion molecule (PECAM/CD31, endothelial cell marker) and -smooth muscle actin (-SMA, 
smooth muscle cell marker) confirmed the successful preparation of cultured endothelial cells from the thoracic 
aorta. (D−I) Fura-2 ratiometric Ca2+ imaging in primary cultured endothelial cells. Tric-a-knockout endothelial 
cells showed normal resting [Ca2+]i and regularly responded to both carbachol (CCh, 10 M) and ATP (10 M). 
Furthermore, after Ca2+ release evoked by CCh and ATP, the mutant cells exhibited normal store-operated Ca2+ 
entry (SOCE) (D−F). Normal SOCE was also detected in the mutant cells, after regular SR Ca2+ leak responses 
induced by ionomycin (IM, Ca2+ ionophore, 1 M) and thapsigargin (TG, Ca2+-pump inhibitor, 1 M) (G−I). Our 
Ca2+ imaging detected no abnormal feature in Ca2+ handling of Tric-a-knockout endothelial cells. The data 
represent the mean ± SEM., and the numbers of mice and cells examined are shown in parentheses. Statistical 
differences between the genotypes are indicated by asterisks (**p<0.01 in t-test). 
 
Figure S6. L-type Ca2+ Channel and BK Channel Currents in Tric-a-Knockout VSMCs 
(A−C) Evaluation of steady-state Ca2+ influx by Mn2+ quench of Fura-2 fluorescence in VSMCs. Quenching of 
Fura-2 fluorescence by Mn2+ entry was monitored, and effects of BayK8644 (1 M) and verapamil (100 M) were 
examined (A and B). Averaged time-courses of the quench in Tric-a-knockout and control VSMCs are illustrated. 
Under non-treated conditions, the quench rate in the mutant cells was significantly accelerated, compared with that 
of wild-type cells. However, similar rates between the genotypes were observed under BayK8644- and 
verapamil-treated conditions. Therefore, BayK8644 strongly facilitated Mn2+ quench in wild-type cells, but not in 
the mutant cells. In contrast, verapamil-sensitive Mn2+ quench was significantly enhanced in the mutant cells (C). 
The observations confirmed our conclusion from Figure 2 that dihydropyridine-sensitive L-type Ca2+ channels are 
hyperactivated under resting conditions in Tric-a-knockout VSMCs. (D and E) L-type Ca2+ channel current 
recording. VSMCs were examined by whole-cell patch clamp using the VDCC pipette solution and depolarized 
from a holding potential of -60 mV to test potentials. Representative current traces at test potentials of -40, -30, -20, 
-10 and 0 mV were obtained in the presence and absence of nicardipine (1 M) (D). Currents evoked at test 
potentials were normalized to membrane capacitance to yield the current density, and the data obtained are 
summarized as current-voltage relationship curves (E). We detected no abnormal characteristics of 
nicardipine-sensitive currents in Tric-a-knockout VSMCs. (F−H) Ca2+-dependent K+ channel currents recording. 
Ca2+-dependent K+ channels are pharmacologically classified into the following three major groups; 
apamin-sensitive small-conductance (SK) channels, TRAM-34-sensitive intermediate-conductance (IK) channels 
and iberiotoxin (IBTX)-sensitive big-conductance (BK) channels. Single VSMCs prepared from wild-type 
mesenteric arteries were examined in whole-cell patch-clamp recording using the STOC pipette solution at a 
holding potential of 0 mV. Active STOCs in a control bathing solution were blocked by IBTX (100 nM), but 
TRAM-34 (1 M) and apamin (100 nM) did not affect STOC generation (F). Therefore, BK channels 
predominantly mediate STOCs in VSMCs from mesenteric arteries. To evaluate cell-surface BK channel density, 
VSMCs were examined using the BK pipette solution and depolarized from a holding potential of -60 mV to test 
potentials in 10 mV steps. Representative current traces before and after IBTX application are shown (G). Currents 
evoked at test potentials were normalized to membrane capacitance to yield the current density, and the data 
obtained are summarized as current-voltage relationship curves (H). We detected no abnormal characteristics of 
IBTX-sensitive currents in Tric-a-knockout VSMCs. The data represent the mean ± SEM., and the numbers of cells 
and mice examined are shown in parentheses. Statistical differences between the genotypes are indicated by 
asterisks (*p<0.05, **p<0.01 in t-test). 
 
Figure S7. Genetic Variations in Human TRIC-A Gene 
(A) Sequencing of TRIC-A segments from 130 Japanese hypertension patients. We sequenced genomic fragments, 
containing exons (E1−E6) and indicated by green arrows on the gene map, and detected several common variations 
with rs IDs (left list) and rare variations without rs ID (right list). Most of the common variations are classified into 
two major groups in linkage disequilibrium; standardized disequilibrium coefficients (D’) and squared 
allele-frequency correlations (r2) are given in each group. Based on the HapMap database and our case-control 
study, the group-I SNPs (red rs ID) are distributed over 80 kb and associated with a hypertension risk, while the 
group-II SNPs (blue rs ID) are restricted to 5 kb and showed no correlation with the risk. (B) LD mapping analysis 
of the TRIC-A genetic region. The LD plot was produced by analyzing representative SNPs with relatively high 
frequencies in the HapMap database. The haplotype variations proposed from the database indicate that LD SNPs 
around the TRIC-A gene cluster to form three blocks. The LD SNPs clustered in blocks 2 and 3 largely retained 
associations with each other in our genotyping analysis, while the SNPs in block 1 do not show high association 
with the block 2 and 3 LD SNPs. In addition to LD SNPs, there are several non-LD SNPs in these blocks. 
Supplemental Tables 
 





Male (%) 49.2 50.8 
Age (years) 58.6 ± 10.4 61.3 ± 8.8 
Body mass index (kg/m2) 23.5 ± 2.9 22.3 ± 2.8 
Systolic blood pressure (mmHg) 160.5 ± 20.6 111.9 ± 7.8 
Diastolic blood pressure (mmHg) 96.9 ± 13.6 69.1 ± 6.8 
Antihypertensive medication (%) 58.2 - 
*Hypertensive cases: subjects who were treated with antihypertensive medication or who had an SBP more than 160 mmHg and/or a 
DBP more than 100 mmHg. **Normotensive controls: subjects who had never been treated with antihypertensive medication and who 













Male (%) 54.8    
Age (years) 58.4 ± 12.2    
Body mass index (kg/m2) 23.9 ± 2.8    
SBP (mmHg) 156.0 ± 13.4 134.9 ± 14.3 134.2 ± 14.2 132.9 ± 11.8 
DBP (mmHg) 94.3 ± 9.6 83.9 ± 10.0 84.5 ± 9.7 82.6 ± 9.1 
MBP(mmHg) 114.9 ± 8.1 100.9 ± 9.6 101.1 ± 9.4 99.4 ± 8.3 
The data represent the mean ± SD. 
 
 
Table S3. TRIC-A SNPs and Antihypertensive Therapy 
rs ID genotype 
ARB             ΔMBP (mmHg) TZD              ΔMBP (mmHg) CCB             ΔMBP (mmHg) 
frequency G11 G12+G22 p frequency G11 G12+G22 p frequency G11 G12+G22 p 
rs8112375 CC/CA/AA 7/51/72 -6.1±13.6 -14.6±8.9 0.019 7/49/68 -12.2±13.7 -13.6±8.7 0.692 7/51/71 -7.5±5.7 -15.7±8.9 0.019
rs10403969 AA/AC/CC 7/51/71 -6.1±9.4 -14.5±9.4 0.020 7/49/67 -12.2±8.8 -13.5±9.1 0.706 7/51/70 -7.5±3.5 -15.6±9.0 0.019
rs730120 AA/AG/GG 3/50/76 -11.8±9.4 -14.2±9.4 0.658 3/48/72 -14.6±8.8 -13.5±9.1 0.845 3/50/75 -9.6±3.5 -15.3±9.0 0.273
rs901792 CC/CT/TT 10/57/63 -6.6±12.6 -14.8±8.8 0.007 10/54/60 -7.5±13.2 -14.0±8.4 0.028 11/56/62 -9.2±9.1 -15.8±8.8 0.020
rs7259569 GG/GA/AA 10/57/63 -6.6±12.6 -14.8±8.8 0.007 10/54/60 -7.5±13.2 -14.0±8.4 0.028 11/56/62 -9.2±9.1 -15.8±8.8 0.020
rs17195267 TT/TC/CC 7/49/73 -14.7±11.9 -14.2±9.2 0.888 7/46/72 -17.7±5.7 -13.3±9.1 0.210 7/49/72 -18.5±5.6 -15.1±9.1 0.331
rs8104526 CC/CA/AA 7/51/72 -14.7±11.9 -14.1±9.2 0.876 7/46/71 -17.7±5.7 -13.3±9.1 0.208 7/51/71 -18.5±5.6 -15.1±9.1 0.323
rs773841 CC/CT/TT 7/51/72 -14.7±11.9 -14.1±9.2 0.876 7/46/71 -17.7±5.7 -13.3±9.1 0.208 7/51/71 -18.5±5.6 -15.1±9.1 0.323
The drug-induced effects on MBP were analyzed in SNP genotypes. The data represent the mean ± SD., and statistical differences 
between the genotypes are indicated by red p values. 
 
 
Table S4. TRIC-A SNPs and Antihypertensive Resistance 
rs ID genotype 
ARB            SBP            DBP TZD           SBP           DBP CCB          SBP           DBP 
frequency  p  p frequency  p  p frequency  p  p 
rs8112375 CC/CA+AA 7/123 2.077 0.655 7.043 0.035 7/117 -4.920 0.316 0.551 0.852 7/122 2.865 0.507 5.461 0.070
rs10403969 AA/AC+CC 7/122 1.993 0.667 7.036 0.036 7/116 -5.005 0.308 0.515 0.863 7/121 2.668 0.525 5.408 0.073
rs730120 AA/AG+GG 3/126 -4.650 0.506 1.428 0.776 3/120 -6.728 0.360 -2.299 0.602 3/125 2.032 0.755 1.979 0.660
rs901792 CC/CT+TT 10/120 3.458 0.378 6.361 0.025 10/114 2.461 0.554 5.201 0.037 11/118 1.996 0.568 4.402 0.074
rs7259569 GG/GA+AA 10/120 3.458 0.378 6.361 0.025 10/114 2.461 0.554 5.201 0.037 11/118 1.995 0.568 4.402 0.074
rs17195267 TT/TC+CC 7/122 1.313 0.777 -1.059 0.750 7/118 -2.920 0.552 -4.725 0.105 7/121 0.574 0.894 -4.869 0.103
rs8104526 CC/CA+AA 7/123 1.274 0.783 -1.108 0.738 7/117 -2.889 0.555 -4.732 0.103 7/122 0.528 0.902 -4.908 0.099
rs773841 CC/CT+TT 7/123 1.274 0.783 -1.108 0.738 7/117 -2.889 0.555 -4.732 0.103 7/122 0.528 0.902 -4.908 0.099
Drug-induced depressor effects were evaluated by adjustment for baseline values. Specific depressor effects of minor allele 
homozygotes are shown as  standardized regression coefficients, and statistical significances are indicated by red p values. 
 




For tggaatgtgttcatgatgctc Adra1a 
mRNA 
For accattgtcacccagaggag Agtr1a 
mRNA 
For ggaaacagcttggtggtgat 
Rev gggaaggtccctggttttc Rev atgatggtcagtggcacgta Rev acataggtgattgccgaagg 
Agtr1b 
mRNA 
For tacgccaaggaatgatgaca Atp2a2 
mRNA 
For agttcatccgctacctcatctca Atp2b3 
mRNA 
For cccctaagatcctcgacctc 
Rev gtccactacgtccgcaattt Rev caccagattgacccagagtaactg Rev cttcaggtccaagacgaagc 
B2m 
mRNA 
For ctgaccggcctgtatgctat Casq1 
mRNA 
For gagcctatgaccatcccaga Cav1.2 
mRNA 
For tgggttttgggaaattgtgt 
Rev ccgttcttcagcatttggat Rev aaaggcgacaatgtggattc Rev cctcattggcttgctctagg 
Cchb2 
mRNA 
For cagggttctcaaggtgatcaaag Cchb3 
mRNA 
For ctcccatcatcgtctttgtcaa Fkbp1a 
mRNA 
For actaggcaagcaggaggtga 
Rev gaggaacggtgttgggatttt Rev gcttatcgtacgccatcatctg Rev ctccataggcatagtctgaggagat
Fkbp1b 
mRNA 
For gagacggaaggacattccctaag Gnaq 
mRNA 
For aggtggatgtggaaaaggtg Itpr1 
mRNA 
For ggaccggacaatggaacagat 
Rev cccttttgaagcattcctgtgt Rev gtccacgtccgtcaggtagt Rev catcccgctctgtggtgtaat 
Jph2 
mRNA 
For aagaagggccgtaaggaagt Kcnma1 
mRNA 
For aatgcacttcgaggaggcta Kcnn1 
mRNA 
For tcaaaaatgctgctgcaaac 
Rev ggccgatgttcagcaagatc Rev ctcagccggtaaattccaaa Rev tcgttcaccttcccttgttc 
Kcnn2 
mRNA 
For gatctggcaaagacccagaa Kcnn3 
mRNA 
For acttcaacacccgattcgtc Kcnn4 
mRNA 
For ggcacctcacagacacactg 
Rev gaagtccctttgctgctgtc Rev ggaaaggaacgtgatggaga Rev tttctccgccttgttgaact 
Ncx1 
mRNA 
For ggaccaacagctggagagag Orai1 
mRNA 
For gccagagttactccgaggtg P2rx1 
mRNA 
For actgggagtgtgacctggac 
Rev ttctgtaggtgggacgaagg Rev cctggtgggtagtcatggtc Rev tcccaaacaccttgaagagg 
Pecam1 
mRNA 
For tgcaggagtccttctccact Plb 
mRNA 
For tacctcactcgctcggctat Plcb1 
mRNA 
For cccaagttgcgtgaacttct 
Rev cagcttcactgctttgcttg Rev gatgcagatcagcagcagac Rev gttgccaagctgaaaacctc 
Plcb2 
mRNA 
For acatccaggaagtggtccag Plcb3 
mRNA 
For caggccagcacagagacata Ptgir 
mRNA 
For ctacgctttctgctgcctct 
Rev cgcaccgactcctttacttc Rev aggatgctggcaatcaaatc Rev agatggaggtcaccaacagg 
Ryr1 
mRNA 
For attacagagcagcccgaggat Ryr2 
mRNA 
For ggcagtatggtccggttaga Ryr3 
mRNA 
For ggccaagaacatcagagtgactaa
Rev agaaccttccgcttgacaaact Rev caatgccagcaaagtcttga Rev tcacttctgccctgtcagtttc 
Sri 
mRNA 
For tggacaggacggacaaattga Stim1 
mRNA 
For agaatgagaggagccgtcaa Tbxa2r 
mRNA 
For cctgctcaacaccgttagtg 
Rev ggcgacaagtctccaggttaaa Rev gcctctctgcattttgcttc Rev atgacaggtggtgtctgcaa 
Tric-a 
mRNA 
For gtgtccaaggccagcctcat Tric-b 
mRNA 
For aaggtgatgaatggctgaagatgtc Tric-a EG 
mRNA 
For gcattcgtcgggcagcgg 




For cttccctgttttcgacctca Tric-a TG 
mRNA 
For tgaggtcgaaaacagggaag Tric-a 
TG 
For caggagctgtggagctgtcccg 
Rev tttacgggcagaaagcagac Rev caggaatcctgtgaagcag Rev ccggtggcgatcatgatgaacc 
Trpc1 
mRNA 
For ctcgaaaggcaaggtcaaac Trpc3 
mRNA 
For ttttccaaatgcaggaggag Trpc4 
mRNA 
For gcgtgctgctgataacttga 






Supplemental Experimental Procedures 
 
Mutant Mice 
Tric-a-knockout mice of C57BL6J and 129 genetic backgrounds were generated and genotyped as described 
previously (Yazawa et al., 2007). For smooth muscle-specific expression of TRIC-A channels, a transgene was 
constructed by inserting the mouse Tric-a cDNA between the human -smooth muscle actin promoter (Nakano et 
al., 1991) and the polyadenylation sequence derived from the pcDNA3.1 expression plasmid (Invitrogen). The 
transgene was microinjected into fertilized Tric-a+/- and Tric-a-/- embryos at the single-cell stage, and the embryos 
were implanted into pseudopregnant foster mice. Transgenic mice were selected by PCR genotyping and Southern 
blotting, and were crossed with Tric-a+/- and Tric-a-/- mice. In this study, all of the experiments were 
predominantly conducted using young-adult male mice (8−12 weeks old), and were conducted with the approval of 
the Animal Research Committee of Kyoto University according to the regulations on the animal experimentation of 
Kyoto University. 
 
Blood Pressure and Heart Rate Monitoring 
To telemetrically monitor arterial blood pressure (BP), the battery-operated PA-C10 pressure transmitter (Data 
Sciences International, St Paul, USA.) was implanted into a mouse under anesthesia with pentobarbital (75 mg/kg). 
The pressure-sensing catheter was inserted into the aortic arch through the right common carotid artery, and the 
transmitter body was placed in a subcutaneous pouch along the right flank. Following the surgery, the mice were 
allowed to recover for at least 1 week. Radio signals from the implanted transmitter were captured by the Physiotel 
RPC-1 receiver (Data Sciences International), and the data were stored online using the Dataquest ART data 
acquisition system (Data Sciences International). BP was monitored in 10-sec episodes at 5-min intervals for 7 days. 
For telemetric monitoring of the electrocardiogram, the ETA-F20 radio frequency transmitter (Data Sciences 
International) was implanted into the peritoneal cavity, and the mouse was allowed to recover for at least 1 week. 
Radio signals were captured by the RPC-1 receiver, and the recording was acquired at a 1-kHz sampling rate and 
heart rate (HR) was determined from R-R intervals. BP and HR in the conscious state were also measured by 
tail-cuff plethysmography (Model BP-98A-L, Softron, Japan), and were evaluated as the average values of 6 trials 
during daytime. BP and HR shifts were examined before and after intraperitoneal injections of various drugs. 
 
Myogenic Tone Measurements 
Arterial diameter measurements were performed as described previously (Iwamoto et al., 2004). Distal mesenteric 
arteries (2−3 mm length, 120−150 µm passive external diameter) were prepared from mice, cannulated at both ends 
and continuously superfused with gassed Krebs-Ringer solution at 37 ºC to induce myogenic tone. For diameter 
monitoring, the arterial outer diameter was continuously monitored by an edge-detection system (National 
Instruments, Austin, USA. or Scion Corporation, Maryland, USA.). 
 
Ca2+ Measurements 
To monitor intracellular Ca2+ levels ([Ca2+]i) in vascular smooth muscle cells (VSMCs) (Iwamoto et al., 2004), the 
inner surface of the mesenteric artery and thoracic aorta was wiped with gauze to remove endothelial cells in a 
physiological salt solution (PSS, in mM: 150 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 5.6 glucose and 5 HEPES, pH 7.4 
with NaOH). The resulting arterial and aortic muscle segments were incubated with 5 M Fura-PE3AM (Santa 
Cruz) and 0.02% cremophor EL (Sigma-Aldrich) for approximately 3 hrs at room temperature (~23 ºC). After 
Fura-PE3 loading, the vascular strip was tightly fixed with fine steel pins onto a silicone rubber sheet, which was 
placed on a glass-bottom dish. A CCD camera (Sensicam, PCO. imaging, Germany) mounted on the microscope 
(DM IRB, Leica), equipped with a polychromatic illumination system (MetaFluor ver6.2r6, Molecular Devices), 
was used to capture the fluorescence images with excitation at 340 and 380 nm, and emission at >510 nm at room 
temperature. Bathing solutions used were PSS, nominally Ca2+-free PSS (0 Ca2+ in Figures 2, S4 and S5) and 
Ca2+-free PSS containing 4 mM EGTA (EGTA in Figures 2 and S4). 
 
Single VSMC Preparations 
Single VSMCs were enzymatically isolated from the mesenteric artery as described previously (Ohi et al., 2001). 
Arterial preparations were freed from other tissues and fat in Ca2+ and Mg2+-free Hanks solution. The tissues were 
incubated in the Ca2+ and Mg2+-free Hanks solution containing 0.2% collagenase (Amano enzyme, Japan), 0.02% 
papain (Sigma-Aldrich) and 0.3−0.6% bovine serum albumin at 37 ºC for 40 min, and then aggressively suspended 
using a cut frontal yellow tip to recover isolated VSMCs in Kraft-Bruhe solution (in mM: 70 potassium glutamate, 
30 KCl, 10 KH2PO4, 1 EGTA, 10 glucose, 10 NaCl, 1 MgCl2 and 10 HEPES, pH 7.2 with N-methyl-D-glucamine). 
 
 
Ca2+ Spark Measurements 
For fluorometric Ca2+ imaging (Ohi et al., 2001), single VSMCs were seeded onto glass-bottom dishes and 
incubated with 5 µM Fluo-4AM (Dojindo, Japan) for 20 min at room temperature (~23 ºC) in HEPES-buffered 
solution (HBS, in mM: 137 NaCl, 5.9 KCl, 2.2 CaCl2, 1.2 MgCl2, 14 glucose and 10 HEPES, pH 7.4 with NaOH). 
After Fluo-4 loading, fluorescence images with excitation at 488 nm and emission at >520 nm were captured using 
a total internal reflection fluorescence microscopy system (TE-2000U, Nikon) equipped with an 
electron-multiplying CCD camera (Hamamatsu Photonics, Japan). The imaging data were analyzed using the 
custom software Aquacosmos (Hamamatsu Photonics). The intracellular fluorescence intensity was normalized to 
the baseline intensity to yield the relative intensity (F/F0). Ca2+ spark amplitude is expressed as an increased  
relative intensity value (F/F0), and a Ca2+ spark was defined as a local fluorescence increase of >0.05 in F/F0. 
The frequency was determined from detectable spark generation during a monitoring period. 
 
Mn2+ Influx Monitoring 
Single VSMCs were seeded onto glass-bottom dishes and incubated with HBS containing 5 µM Fura-2AM 
(Dojindo) for 30 min at 37 ºC. A CCD camera (Sensicam) mounted on the microscope (DM IRB), equipped with a 
polychromatic illumination system (MetaFluor ver6.2r6), was used to capture the fluorescence images with 
excitation at 360 nm, and emission at >510 nm at room temperature (~23 ºC). In the measurements, PSS was used 
as a standard bathing solution and quenching of Fura-2 fluorescence was induced by Ca2+-free PSS supplemented 
with 500 µM MnCl2 in the presence and absence of L-type Ca2+ channel modulators (Hashii et al., 2000). 
 
Patch-Clamp Recording 
Whole-cell voltage clamp recording with patch pipettes (2 to 5 MΩ in pipette resistance and approximately 30 GΩ 
in seal resistance) was carried out using the Axopatch 200B amplifier (Molecular Device, CA, USA) essentially as 
described previously (Hotta et al., 2007; Ohi et al., 2001). For spontaneous transient outward current (STOC) 
monitoring in single VSMC (Figures 3 and S6F), the STOC pipette solution (in mM: 140 KCl, 4 MgCl2, 5 Na2ATP, 
0.05 EGTA and 10 HEPES, pH 7.2 with KOH) and HBS as a bathing solution were utilized. For recording of total 
Ca2+-dependent K+ currents (Figure S6G and S6H), the BK pipette solution (in mM: 140 KCl, 1 MgCl2, 6.1 CaCl2, 
1 Na2ATP and 10 EGTA and 10 HEPES, pH 7.2 with KOH, pCa 6.5) and HBS containing 100 M CdCl2 as a 
bathing solution were utilized. For recording of voltage-dependent Ca2+ channel currents (Figure S6D and S6E), 
following solutions were used; the VDCC pipette solution (in mM: 120 CsCl, 20 tetraethylammonium, 1 MgCl2, 10 
HEPES, 5 EGTA and 2 Na2ATP, pH 7.2 with CsOH), and the bathing solution (in mM: 30 tetraethylammonium, 1 
4-aminopyridine, 107 NaCl, 5.9 KCl, 2.2 CaCl2, 1.2 MgCl2, 14 glucose and 10 HEPES, pH 7.4 with NaOH). All 
experiments were carried out at room temperature (~23 ºC). 
 
Membrane Potential Monitoring 
Single VSMCs were seeded onto glass-bottom dishes and perfused with HBS containing 200 nM oxonol VI (Fluka) 
for 20 min at room temperature (~23 ºC). During membrane potential recording in the continuous presence of 200 
nM oxonol VI, hyperpolarization results in extrusion of the dye from cells to subsequently decrease cellular 
fluorescence intensity (Apell and Bersch, 1987). To prepare the calibration plot showing the relationship between 
the fluorescence intensity and membrane potential, HBS solutions containing 20 mM, 30 mM, 60 mM or 140 mM 
KCl were used as bathing solutions. Fluorescence images with excitation at 559 nm and emission at >606 nm were 
captured at a sampling rate of ~1.6 s using a confocal microscope system (FV1000, Olympus, Japan) as described 
previously (Masumiya et al., 2009). 
 
Tension Measurements of Aortic Ring Preparations 
Isometric tension of ring preparations from the thoracic aorta (~4 mm in length) was measured as described 
previously (Iwamoto et al., 2004). Using two thin steel wires, the ring was tied to a force transducer and suspended 
in Krebs-Henseleit solution (in mM: 118 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgSO4, 2.5 CaCl2, 25 NaHCO3 and 11.7 
glucose, pH 7.4 with NaOH) bubbled with 95% O2 and 5% CO2 at 37 °C. The ring preparations were stabilized at a 
resting tension of 1 g for 1 hr before recording contractile responses. 
 
Cultured Endothelial Cells 
Endothelial cells were isolated from the thoracic aorta in a collagenase-containing solution and cultured in DMEM 
supplemented with 20% fetal bovine serum and growth supplements essentially as described previously (Kobayashi 
et al., 2005). After culturing for 72−96 hrs, endothelial cells were used for immunochemistry and Ca2+ imaging. 
The cells were fixed with 10% formalin for 15 min, treated with a blocking buffer (3% BSA and 0.1% TritonX-100 
in PBS) for 10 min, and subjected to immunostaining using anti-mouse CD31 antibody (550274, BD Pharmagen) 
and anti-human -smooth muscle actin antibody (ab5694, Abcam). For ratiometric Ca2+ imaging, the cells were 
loaded with 5 μM Fura-2AM for 45 min at room temperature (~23 ºC) and examined as described previously 
(Yamazaki et al., 2009). 
 
Anatomical Analysis 
Vascular tissues were examined by light and electron microscopes as described previously (Yazawa et al., 2007). 
The tissues were treated in a fixative solution containing 3% paraformaldehyde, 2.5% glutaraldehyde and 0.1 M 
sodium cacodylate (pH 7.4), and were postfixed with 1% OsO4 in the same buffer. The fixed tissues were washed, 
dehydrated and embedded in epoxy resin. Thin sections (approximately 1 m thick) were stained with toluidine 
blue for observation using light microscopy. Ultrathin sections (approximately 80 nm thick) were stained with 
uranyl acetate and lead citrate, and were examined using an electron-microscope (JEM-1010, JEOL, Japan). 
 
RT-PCR Analysis 
For quantitative PCR analysis (Hotta et al., 2007), total RNA preparations from various tissues (at least 3 mice in 
each genotype) were used as templates for cDNA synthesis (ReverTra ACE qPCR-RT kit, Toyobo, Japan) and 
analyzed using a real-time PCR system according to the manufacturer’s instructions (Thermal Cycler TP800, 
Takara, Japan). The cycle threshold (Ct) was determined from the cDNA amplification curve as an index for 
relative mRNA content in each reaction. The PCR primers used in this study are listed in Table S5. 
 
Case-Control Study 
Hypertensive cases and normotensive controls were recruited from the Asahikawa, Tokyo, Osaka, and Hiroshima 
regions of Japan according to the following criteria. Hypertensive subjects (n=758) had a previous diagnosis of 
hypertension between 30 and 59 years of age, and they were either being treated with antihypertensive medication 
or had an SBP more than 160 mmHg and/or a DBP more than 100 mmHg. They had a family history of 
hypertension in their parents and/or siblings and were not obese (BMI less than 25 kg/m2). Normotensive controls 
(n=726) aged more than 45 years were recruited from the same regions. These individuals had never been treated 
with antihypertensive medications and their SBP was less than 120 mmHg and DBP less than 80 mmHg. They had 
no family history of hypertension. Additional cases and controls were chosen from two population-based samples, 
the Nomura and Matsuyama cohorts, according to the same criteria. The Nomura study is a longitudinal 
epidemiological study on Nomura residents, a largely rural community located in Ehime Prefecture (western part of 
Japan). Subjects were recruited through a community-based annual medical check-up process. Subjects in the 
Matsuyama cohorts were derived from employees of large manufacturing industries located in Matsuyama, Ehime 
Prefecture. In all cohorts, clinical parameters were obtained from personal health records during the annual medical 
check-up process. All study procedures were approved by the ethics committee of each steering university. Signed 
informed consent was obtained from all participating subjects. Genomic DNAs extracted from blood samples were 
subjected to SNP genotyping around the TRIC-A gene with the TaqMan probe assay using commercially available 
primers and probes purchased from the Assay-on-Demand system (Applied Biosystems). Frequency differences in 
each SNP were assessed by the chi-square test, and differences in BP levels among genotypes were assessed using 
PLINK software (Purcell et al., 2007; http://pngu.mgh.harvard.edu/~purcell/plink/). 
 
GEANE Study 
The “GEANE study” (Gene evaluation for antihypertensive effects of drugs study; multicenter clinical trial 
registry: UMIN-CRT-C000000119) utilized an open random crossover protocol to examine the antihypertensive 
effects of valsartan (ARB, 80 mg/day), indapamide (TZD, 2 mg/day) and amlodipine (CCB, 5 mg/day). The study 
subjects (Table S2) were untreated Japanese with essential hypertension (stage 1 and 2 patients with SBP 140−179 
mmHg or DBP 90−109 mmHg; see the guideline in the Japanese Society of Hypertension). After informed consent, 
each drug was prescribed for three months, starting at one half the final does and increasing to the regular dose; the 
order of the three administered drugs was individually randomized. On the last day of each medication, BP was 
determined and blood samples were collected for SNP genotyping and regular blood chemical analysis. SNP 
genotypes were determined with the GeneChip Human Mapping 500K Set. (Affymetrix). The data were examined 
using the PLINK software in the following two evaluation models; (i) linear regression for differences in BP from 
pre-medication to post-medication with only SNPs as a fixed effect (Table S3) and (ii) linear regression for 
post-medication BP with SNPs and pre-medication BP as covariates (Table S4). 
